{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:05:57Z","timestamp":1784991957589,"version":"3.55.0"},"reference-count":32,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100020588","name":"HeartFlow Inc.","doi-asserted-by":"crossref","award":["Institutional support to Pauls Stradins Clinical U"],"award-info":[{"award-number":["Institutional support to Pauls Stradins Clinical U"]}],"id":[{"id":"10.13039\/100020588","id-type":"DOI","asserted-by":"crossref"}]},{"name":"State Research Program of the Latvian Ministry of Healthcare","award":["VPP-VM-Veseliba-2023\/3-0004"],"award-info":[{"award-number":["VPP-VM-Veseliba-2023\/3-0004"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Endovasc Ther"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      To determine whether diagnosis of asymptomatic (silent) coronary ischemia using coronary computed tomography (CT)-derived fractional flow reserve (FFR\n                      <jats:sub>CT<\/jats:sub>\n                      ) together with targeted coronary revascularization of ischemia-producing coronary lesions following lower-extremity revascularization can reduce adverse cardiac events and improve long-term survival of patients with chronic limb-threatening ischemia (CLTI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>\n                      Prospective cohort study of CLTI patients with no cardiac history or symptoms undergoing elective lower-extremity revascularization. Patients with pre-operative coronary computed tomography angiography (CTA) and FFR\n                      <jats:sub>CT<\/jats:sub>\n                      evaluation with selective post-operative coronary revascularization (FFR\n                      <jats:sub>CT<\/jats:sub>\n                      group) were compared with patients with standard pre-operative evaluation and no post-operative coronary revascularization (control group). Lesion-specific coronary ischemia was defined as FFR\n                      <jats:sub>CT<\/jats:sub>\n                      \u22640.80 distal to a coronary stenosis with FFR\n                      <jats:sub>CT<\/jats:sub>\n                      \u22640.75 indicating severe ischemia. Endpoints included all-cause death, cardiac death, myocardial infarction (MI) and major adverse cardiovascular (CV) events (MACE=CV death, MI, stroke, or unplanned coronary revascularization) during 5 year follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In the FFR\n                      <jats:sub>CT<\/jats:sub>\n                      group (n=111), FFR\n                      <jats:sub>CT<\/jats:sub>\n                      analysis revealed asymptomatic (silent) coronary ischemia (FFR\n                      <jats:sub>CT<\/jats:sub>\n                      \u22640.80) in 69% of patients, with severe ischemia (FFR\n                      <jats:sub>CT<\/jats:sub>\n                      \u22640.75) in 58%, left main ischemia in 8%, and multivessel ischemia in 40% of patients. The status of coronary ischemia in the control group (n=120) was unknown. Following lower-extremity revascularization, 42% of patients in FFR\n                      <jats:sub>CT<\/jats:sub>\n                      had elective coronary revascularization with no elective revascularization in controls. Both groups received guideline-directed medical therapy. During 5 year follow-up, compared with control, the FFR\n                      <jats:sub>CT<\/jats:sub>\n                      group had fewer all-cause deaths (24% vs 47%, hazard ratio [HR]=0.43 [95% confidence interval [CI]=0.27-0.69], p&lt;0.001), fewer cardiac deaths (5% vs 26%, HR=0.18 [95% CI=0.07-0.45], p&lt;0.001), fewer MIs (7% vs 28%, HR=0.21 [95% CI=0.10-0.47], p&lt;0.001), and fewer MACE events (14% vs 39%, HR=0.28 [95% CI=0.15-0.51], p&lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Ischemia-guided coronary revascularization of CLTI patients with asymptomatic (silent) coronary ischemia following lower-extremity revascularization resulted in more than 2-fold reduction in all-cause death, cardiac death, MI, and MACE with improved 5 year survival compared with patients with standard cardiac evaluation and care (76% vs 53%, p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Impact<\/jats:title>\n                    <jats:p>Silent coronary ischemia in patients with chronic limb-threatening ischemia (CLTI) is common even in the absence of cardiac history or symptoms. FFRCT is a convenient tool to diagnose silent coronary ischemia perioperatively. Our data suggest that post-surgery elective FFRCT-guided coronary revascularization reduces adverse cardiac events and improves long-term survival in this very-high risk patient group. Randomized study is warranted to finally test this concept.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15266028241245909","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T03:00:55Z","timestamp":1713150055000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Ischemia-Guided Coronary Revascularization Following Lower-Extremity Revascularization Improves 5-Year Survival of Patients With Chronic Limb-Threatening Ischemia"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1322-7920","authenticated-orcid":false,"given":"Gustavs","family":"Latkovskis","sequence":"first","affiliation":[{"name":"Pauls Stradins Clinical University Hospital, Riga, Latvia"},{"name":"University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dainis","family":"Krievins","sequence":"additional","affiliation":[{"name":"Pauls Stradins Clinical University Hospital, Riga, Latvia"},{"name":"University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4452-4389","authenticated-orcid":false,"given":"Edgars","family":"Zellans","sequence":"additional","affiliation":[{"name":"Pauls Stradins Clinical University Hospital, Riga, Latvia"},{"name":"University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indulis","family":"Kumsars","sequence":"additional","affiliation":[{"name":"Pauls Stradins Clinical University Hospital, Riga, Latvia"},{"name":"University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agate","family":"Krievina","sequence":"additional","affiliation":[{"name":"University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Angena","sequence":"additional","affiliation":[{"name":"University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanda","family":"Jegere","sequence":"additional","affiliation":[{"name":"Pauls Stradins Clinical University Hospital, Riga, Latvia"},{"name":"University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrejs","family":"Erglis","sequence":"additional","affiliation":[{"name":"Pauls Stradins Clinical University Hospital, Riga, Latvia"},{"name":"University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigars","family":"Lacis","sequence":"additional","affiliation":[{"name":"Pauls Stradins Clinical University Hospital, Riga, Latvia"},{"name":"Riga Stradins University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Zarins","sequence":"additional","affiliation":[{"name":"HeartFlow, Redwood City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2017.07.018"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.12.012"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2017.07.005"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad022"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198402000-00016"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2016.03.429"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.2738"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207899"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00462-2"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.008"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041905"},{"key":"e_1_3_3_14_2","article-title":"2021 ACC\/AHA\/SCAI Guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Lawton JS","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC\/AHA\/SCAI Guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circ. 2022;145:e18\u2013e114.","journal-title":"Circ"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803538"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy812"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.07.068"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.07.043"},{"key":"e_1_3_3_19_2","first-page":"3689","article-title":"Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease","volume":"39","author":"Collet C","year":"2018","unstructured":"Collet C, Onuma Y, Andreini D, et al. Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease. Eur Heart J. 2018;39:3689\u20133698.","journal-title":"Eur Heart J"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.07.052"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2020.05.027"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2021.03.059"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcct.2016.10.002"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029289"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab246"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805971"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915922"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.04.083"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2018.03.021"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2030413"},{"key":"e_1_3_3_32_2","first-page":"93","article-title":"FFRCT-guided revascularization of silent coronary ischemia compared to best medical therapy following lower-extremity revascularization","volume":"13","author":"Latkovskis G","year":"2021","unstructured":"Latkovskis G, Zellans E, Krievina A, et al. FFRCT-guided revascularization of silent coronary ischemia compared to best medical therapy following lower-extremity revascularization. Interv Cardiol. 2021;13(S5):93\u2013102.","journal-title":"Interv Cardiol"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.05.005"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028241245909","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15266028241245909","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028241245909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:30:40Z","timestamp":1777498240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15266028241245909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1177\/15266028241245909"],"URL":"https:\/\/doi.org\/10.1177\/15266028241245909","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]}}}